THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2

Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JETTE, Claudia A, WANG, Jingzhou, VIELMETTER, Jost G, CHARTRON, Justin W, BARNES, Christopher O, CONTRERAS, Stephanie C, WEST, JR, CHANG, Paul M, BJORKMAN, Pamela J, KEEFFE, Jennifer R, MAYO, Stephen L, ACEVES, Aiden J, OLAFSON, Barry D
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JETTE, Claudia A
WANG, Jingzhou
VIELMETTER, Jost G
CHARTRON, Justin W
BARNES, Christopher O
CONTRERAS, Stephanie C
WEST, JR
CHANG, Paul M
BJORKMAN, Pamela J
KEEFFE, Jennifer R
MAYO, Stephen L
ACEVES, Aiden J
OLAFSON, Barry D
description Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024020582A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024020582A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024020582A13</originalsourceid><addsrcrecordid>eNrjZDAK8XANcgxwDQ3xdFbwA1JBjj6eUZ5-7gqOfiGeTv4unq7BCm7-QQrBjkHBus7-YbpGPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPtzfyMDIxMDIwNTCyNHQmDhVACe0J8s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2</title><source>esp@cenet</source><creator>JETTE, Claudia A ; WANG, Jingzhou ; VIELMETTER, Jost G ; CHARTRON, Justin W ; BARNES, Christopher O ; CONTRERAS, Stephanie C ; WEST, JR ; CHANG, Paul M ; BJORKMAN, Pamela J ; KEEFFE, Jennifer R ; MAYO, Stephen L ; ACEVES, Aiden J ; OLAFSON, Barry D</creator><creatorcontrib>JETTE, Claudia A ; WANG, Jingzhou ; VIELMETTER, Jost G ; CHARTRON, Justin W ; BARNES, Christopher O ; CONTRERAS, Stephanie C ; WEST, JR ; CHANG, Paul M ; BJORKMAN, Pamela J ; KEEFFE, Jennifer R ; MAYO, Stephen L ; ACEVES, Aiden J ; OLAFSON, Barry D</creatorcontrib><description>Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240125&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024020582A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240125&amp;DB=EPODOC&amp;CC=WO&amp;NR=2024020582A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JETTE, Claudia A</creatorcontrib><creatorcontrib>WANG, Jingzhou</creatorcontrib><creatorcontrib>VIELMETTER, Jost G</creatorcontrib><creatorcontrib>CHARTRON, Justin W</creatorcontrib><creatorcontrib>BARNES, Christopher O</creatorcontrib><creatorcontrib>CONTRERAS, Stephanie C</creatorcontrib><creatorcontrib>WEST, JR</creatorcontrib><creatorcontrib>CHANG, Paul M</creatorcontrib><creatorcontrib>BJORKMAN, Pamela J</creatorcontrib><creatorcontrib>KEEFFE, Jennifer R</creatorcontrib><creatorcontrib>MAYO, Stephen L</creatorcontrib><creatorcontrib>ACEVES, Aiden J</creatorcontrib><creatorcontrib>OLAFSON, Barry D</creatorcontrib><title>THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2</title><description>Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAK8XANcgxwDQ3xdFbwA1JBjj6eUZ5-7gqOfiGeTv4unq7BCm7-QQrBjkHBus7-YbpGPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPtzfyMDIxMDIwNTCyNHQmDhVACe0J8s</recordid><startdate>20240125</startdate><enddate>20240125</enddate><creator>JETTE, Claudia A</creator><creator>WANG, Jingzhou</creator><creator>VIELMETTER, Jost G</creator><creator>CHARTRON, Justin W</creator><creator>BARNES, Christopher O</creator><creator>CONTRERAS, Stephanie C</creator><creator>WEST, JR</creator><creator>CHANG, Paul M</creator><creator>BJORKMAN, Pamela J</creator><creator>KEEFFE, Jennifer R</creator><creator>MAYO, Stephen L</creator><creator>ACEVES, Aiden J</creator><creator>OLAFSON, Barry D</creator><scope>EVB</scope></search><sort><creationdate>20240125</creationdate><title>THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2</title><author>JETTE, Claudia A ; WANG, Jingzhou ; VIELMETTER, Jost G ; CHARTRON, Justin W ; BARNES, Christopher O ; CONTRERAS, Stephanie C ; WEST, JR ; CHANG, Paul M ; BJORKMAN, Pamela J ; KEEFFE, Jennifer R ; MAYO, Stephen L ; ACEVES, Aiden J ; OLAFSON, Barry D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024020582A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JETTE, Claudia A</creatorcontrib><creatorcontrib>WANG, Jingzhou</creatorcontrib><creatorcontrib>VIELMETTER, Jost G</creatorcontrib><creatorcontrib>CHARTRON, Justin W</creatorcontrib><creatorcontrib>BARNES, Christopher O</creatorcontrib><creatorcontrib>CONTRERAS, Stephanie C</creatorcontrib><creatorcontrib>WEST, JR</creatorcontrib><creatorcontrib>CHANG, Paul M</creatorcontrib><creatorcontrib>BJORKMAN, Pamela J</creatorcontrib><creatorcontrib>KEEFFE, Jennifer R</creatorcontrib><creatorcontrib>MAYO, Stephen L</creatorcontrib><creatorcontrib>ACEVES, Aiden J</creatorcontrib><creatorcontrib>OLAFSON, Barry D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JETTE, Claudia A</au><au>WANG, Jingzhou</au><au>VIELMETTER, Jost G</au><au>CHARTRON, Justin W</au><au>BARNES, Christopher O</au><au>CONTRERAS, Stephanie C</au><au>WEST, JR</au><au>CHANG, Paul M</au><au>BJORKMAN, Pamela J</au><au>KEEFFE, Jennifer R</au><au>MAYO, Stephen L</au><au>ACEVES, Aiden J</au><au>OLAFSON, Barry D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2</title><date>2024-01-25</date><risdate>2024</risdate><abstract>Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2024020582A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T16%3A24%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JETTE,%20Claudia%20A&rft.date=2024-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024020582A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true